临床分离的129株鲍曼不动杆菌的耐药性分析

    Analysis of clinical distribution and drug resistance of the Bauman acinetobacter

    • 摘要: 目的:了解鲍曼不动杆菌的耐药和临床分布情况,为防控医院感染提供依据。方法:对129株鲍曼不动杆菌的临床分布和常用抗菌药物的耐药情况进行分析。结果:痰标本检出率最高,为72.09%;患者主要分布在内科和重症监护治疗病房;分离出的129株鲍曼不动杆菌仅有3种药物耐药率;30%,分别是亚胺培南(24.80%)、哌拉西林/他唑巴坦(26.35%)、氨苄西林/舒巴坦(27.9%),其余药物耐药率均;50%。结论:鲍曼不动杆菌多重耐药严重,应加强耐药性监测,了解耐药变迁,为临床用药提供依据。

       

      Abstract: Objective:To explore the drug resistance and clinical distribution of Bauman acinetobacter,and provide a basis for controlling hospital infection. Methods:The clinical distribution,drug resistance and sample separation of 129 strains of Bauman acinetobacter were analysed,and the resistance rate of 14 kinds of commonly used antimicrobial agents were calculated. Results:Sputum specimens detection rate with 72.09% was highest,patients came mainly from physicians and intensive care treatment ward.The drug resistance rates of only 3 types of antimicrobial agents in 129 stains Bauman acinetobacter were less than 30%,imipenem,piperacillin/tazobactam and ampicillin/Shu TAZ were 24.80%,26.35% and 27.90%,respectively,the others drug resistance rates were more than 50%. Conclusions:As to the serious multi-drug resistance of Bauman acinetobacters,the resistance monitoring should be strengthened for directing clinical medication.

       

    /

    返回文章
    返回